MDIN - MedGen, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD

MedGen, Inc.

2901 East Gate City Boulevard
Suite 2400
Greensboro, NC 27401
United States

SectorConsumer Defensive
IndustryPharmaceutical Retailers
Full Time Employees1

Key Executives

NameTitlePayExercisedYear Born
Mr. Nicholas ChiecoChairman, Pres, COO, Treasurer & Sec.N/AN/AN/A
Mr. Matthew BriggsChief Exec. OfficerN/AN/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


MedGen, Inc. produces and sells healthcare products worldwide. It operates in four segments: Biomedical, Healthcare, Precision Medicine, and Pharmaceutical. The company offers anti-snoring sprays and natural sleep aid oral sprays, anti-aging drops for pets, and stem cell therapy muscle builder products. It also provides alternative healthcare and natural remedies, including Sombium, a high potency sleep aid; Focamine that promotes focus and attention; Relaxapro, an anti-anxiety capsule; and a medical marijuana liquid beverage. The company was formerly known as Northstar Global Business Services, Inc. and changed its name to MedGen, Inc. in July 2015. MedGen, Inc. was founded in 1996 and is based in Greensboro, North Carolina.

Corporate Governance

MedGen, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.